Skip to main content

Geron Corporation (NASDAQ:GERN) Investor Filed Lawsuit Against Certain Directors Over Alleged Wrongdoing

  • If you purchased shares of Geron Corporation (NASDAQ:GERN) prior to March 2014 and currently hold any of those NASDAQ:GERN shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 1, 2015 (Shareholders Foundation) - An investor in NASDAQ:GERN shares filed a lawsuit against certain of Geron over alleged breaches of fiduciary duties that caused damages to the company and its stockholders. The plaintiff claims that defendants failed to side effects of its sole product, a cancer drug, and shares of Geron Corporation (NASDAQ:GERN) declined from $4.40 to ...

You must register (for free) or login to view the entire case.